Teva Announces Reintroduction of Generic Depo-Provera in the United States

JERUSALEM--(BUSINESS WIRE)--Sep. 25, 2017-- Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the reintroduction of the generic equivalent to Depo-Provera1 Contraceptive Injection (medroxyprogesterone acetate injectable suspension,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news